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Abstract
Background:  Since caspases are key executioners of apoptosis in cases of severe diseases
including neurodegenerative disorders such as Alzheimer's disease and Huntington's disease, and
viral infection diseases such as AIDS and hepatitis, potent and specific inhibitors of caspases have
clinical potential. A series of peptide inhibitors has been designed based on cleavage sites of
substrate proteins. However, these peptides are not necessarily the most potent to each caspase.
Moreover, so far, it has proved to be difficult to design potent and specific peptide inhibitors of
each caspase from sequence data of known cleavage sites in substrate proteins. We have attempted
to develop a computational screening system for rapid selection of potent and specific peptide
inhibitors from a comprehensive peptide library.
Results: We developed a new method for rapid evaluation and screening of peptide inhibitors
based on Amino acid Positional Fitness (APF) score. By using this score, all known peptide
inhibitors of each caspases-3,-7,-8, and -9 were rapidly selected in their enriched libraries. In this
libraries, there were good correlations between predicted binding affinities of the known peptide
inhibitors and their experimental Ki values. Furthermore, a novel potent peptide inhibitor, Ac-
DNLD-CHO, for caspase-3 was able to be designed by this method. To our knowledge, DNLD is
a first reported caspase-3 inhibitory peptide identified by using the computational screening
strategy.
Conclusion: Our new method for rapid screening of peptide inhibitors using APF score is an
efficient strategy to select potent and specific peptide inhibitors from a comprehensive peptide
library. Thus, the APF method has the potential to become a valuable approach for the discovery
of the most effective peptide inhibitors. Moreover, it is anticipated that these peptide inhibitors can
serve as leads for further drug design and optimization of small molecular inhibitors.
Background
Caspases are cysteine aspartyl proteases that play critical
roles during the execution of apoptosis [1-5]. Caspases
have been found in organisms ranging from C. elegans to
humans. The 14 types of caspase (named caspase-1 to cas-
pase-14) identified so far in mammals are suggested to
play distinct roles in apoptosis and inflammation. The
main caspase cascades are catalyzed by caspases-8 and -9
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(initiator caspases) and caspases-3 and -7 (executioner
caspases) [4,5]. The disregulation of caspase cascade acti-
vation is suggested to be involved as a key factor for the
development of a variety of diseases, including neurode-
generative disorders and cancers [6-9].
Caspases share similarities in amino acid sequence, struc-
ture and substrate specificity, and are characterized by an
almost absolute specificity in the active sites for aspartic
acid in the P1 position of substrate proteins. Each active
site contains a positively charged S1 subsite that binds the
negatively charged P1 aspartate on the substrate [10-13].
This S1 binding site is highly conserved; therefore, all cas-
pases cleave solely after aspartate residues. Recognition of
at least four amino acids (P1-P4) in the cleavage sites is
also a necessary requirement for efficient catalysis. Indi-
vidual caspases have been shown to have structural differ-
ences in the predicted S2-S4 substrate binding sites which
vary significantly, resulting in varied substrate specificities
for the P2-P4 positions, despite an absolute requirement
for aspartate in the P1 position [10-16].
The interactions between caspases and their target sub-
strate proteins are highly flexible, so that many caspase
inhibitory peptides, which are derived from natural sub-
strates, are recognized by several members of the caspase
family. For instance, the sequence DEVD within
poly(ADP-ribose) polymerase (PARP) [17] is known to be
recognized and cleaved by caspase-3, and it has been
applied to creating the tetrapeptide inhibitor Ac-DEVD-
CHO. However, Ac-DEVD-CHO also shows similar inhib-
itory activity toward caspases-7, and -8 as well as caspase-
3 [18]. Therefore, it is difficult to design selective caspase
inhibitory peptides based on the sequence of known
cleavage sites.
To identify the sequence with the highest binding affinity
for each caspase, the X-X-X-D (X any of the 20 amino
acids) peptide sequence motif is utilized for Structure-
Based Virtual Screening (SBVS), which involves 203, i.e.,
8000, ∆Gbind evaluations. In order to show each amino
acid position clearly, the X-X-X-D motif is expressed as P4-
P3-P2-D. In SBVS using a library consisting of hundreds of
thousands small molecules, it is necessary to limit the
computing time per compound to at most 1 min. How-
ever, even side chains of a peptide with only 4 amino acids
have a maximum of 20 rotational bonds. In flexible dock-
ing using AutoDock3.0 [19] with default parameters, a
computing time of about 20 min per 4-amino acid pep-
tide on a COMPAQ Alphastation DS20E (double 833
MHz processors and 1024 MB of memory) is required. In
the case of the design of a 5-amino acid peptide, it is nec-
essary to carry out 3.2 million ∆Gbind calculations, so that
comprehensive peptide screening is practically difficult.
Moreover, the computing time for ∆Gbind calculation can
be traded off against accuracy. Therefore, the most prob-
lematic aspect of ∆Gbind calculation is time-consumption
for SBVS.
Alternatively, various pattern-recognition techniques have
been used to analyze peptide cleavage data [20,21]. A sta-
tistical technique has been used to calculate binding free
energy in the analysis of resistance-evading, peptide
mimetic inhibitors of HIV-1 protease [22]. These types of
methods are enough to make potent peptide screening
tractable. However, many experimental data points are
needed to construct a highly precise scoring function.
In the present study, we have developed a new computa-
tional screening strategy based on Amino Acid Positional
Fitness (APF) score for rapid evaluation of peptides inter-
acting specifically with a target protein molecule. In our
system, 1 to 10% of peptides are extracted at random from
a comprehensive peptide library. The ∆Gbinds between the
extracted peptides and the target protein are calculated
using AutoDock3.0, and then the data are transferred to
obtain the APF score for each amino acid position (for
example; P2, P3, and P4 in caspases) using a statistical tech-
nique. Consequently, this score is able to evaluate rapidly
the ∆Gbinds of all peptides in the comprehensive peptide
library. We show here the usefulness of this APF method
for the screening of potent and specific peptide inhibitors
of main caspase family members.
Results and Discussion
Evaluation of binding modes and affinities of caspase 
inhibitory peptides by AutoDock3.0
One of goals of this work is the development of a simple
and fast scoring function (APF score matrix) for the pre-
diction of binding affinities of peptides against target pro-
tein molecules. The APF score matrix is derived from the
predicted binding modes and affinities based on a stand-
ard docking program, AutoDock3.0. It is, therefore,
important to verify the docking results of AutoDock3.0.
Initially, we used Root of Mean Squared Deviation
(RMSD) value as an indicator of the quality of the pre-
dicted binding modes. The RMSD was determined for the
atomic positions between the predicted binding mode of
peptide and native one as found in the crystal structure.
The crystal structures of caspase-3 (1PAU), caspase-7
(1F1J), caspase-8 (1QTN), and caspase-9 (1JXQ) were
used to validate the quality of predicted binding modes.
AutoDock3.0 uses a rapid grid-based lookup method for
energy evaluation. The use of interaction energy grids
allows the use of a sophisticated empirical free energy
force field, while greatly reducing the computational
demands of the docking simulation. In this study, the
Lamarckian Genetic Algorithm (LGA), which combines a
genetic algorithm and a local search algorithm, was usedBMC Pharmacology 2004, 4 http://www.biomedcentral.com/1471-2210/4/7
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as the search method. Since the docking parameters of
AutoDock3.0 affect the qualities of predicted binding
modes and affinities, the number of energy evaluations is
an important docking parameters [23]. So, we investi-
gated the effect of the number of energy evaluations on
the quality of the predicted binding mode of peptide (Fig-
ure 1). Other docking parameters were set to the default
values. In the case of a fixed main chain, the RMSD values
were roughly constant and less than 2 Å in all cases. In
contrast, when all of rotational torsion angles were flexi-
ble (full flexible), the number of energy evaluations does
have an influence. Below 1.5 million energy evaluations,
the RMSD values of caspase-7/DEVD were more than 2.0
Å (Figure 1b). More than 3 million energy evaluations are
required to predict the binding mode of peptide with an
RMSD of less than 2.0 Å with respect to the crystal struc-
tures of the four caspases.
In Structure-Based Virtual Screening (SBVS), the comput-
ing time for evaluation of binding affinity is an important
factor, as well as computational accuracy. Figure 2 shows
the relationship between the number of energy evalua-
tions and the average of the computing time on COMPAQ
Alphastation DS20E. For example, in 0.7 million energy
Effects of the number of energy evaluations on the quality of the predicted binding mode of peptide Figure 1
Effects of the number of energy evaluations on the quality of the predicted binding mode of peptide. The RMSD 
value is used as an indicator of the quality of the predicted binding mode, and is determined for the atomic positions of the pre-
dicted binding mode of peptide and the native one as found in the crystal structure. (a) caspase-3/DEVD, (b) caspase-7/DEVD, 
(c) caspase-8/IETD, (d) caspse-9/LEHD. During the docking, the main chain angles of peptides are fixed (◆ ) or flexible (■ ).BMC Pharmacology 2004, 4 http://www.biomedcentral.com/1471-2210/4/7
Page 4 of 17
(page number not for citation purposes)
Effects of the number of energy evaluations on the computing time Figure 2
Effects of the number of energy evaluations on the computing time. The computing times were measured in the var-
ious number of energy evaluations. During the docking, the main chain angles of peptides are fixed (◆ ) or flexible (■ ).
Table 1: Inhibition of caspases by peptide aldehydes [18]
Caspase-3 Caspase-7 Caspase-8 Caspase-9
DEVD 0.23 1.6 0.92 60
IETD 195 3280 1.05 108
WEHD 1960 >10,000 21.1 508
AEVD 42 425 1.6 48
YVAD >10,000 >10,000 352 970
Ki (nM)BMC Pharmacology 2004, 4 http://www.biomedcentral.com/1471-2210/4/7
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evaluations and with a fixed main chain, the average com-
puting time was about 10 min (Figure 2). This is
reasonable time per peptide for constructing the APF score
matrix. However, fixation of the main chain during dock-
ing may affect the quality of docking results of inhibitory
peptides with arbitrary amino acid sequences. So, we
compared our docking results of well-known peptide
inhibitors of caspases-3,-7,-8, and -9 with their experi-
mental data (Table 1) previously reported (Table 2). In
this experiment, to generate the initial conformations of
these peptides, the crystallographic structures were used
for the main chain coordinate of the inhibitory peptides,
and then the side chains were added. Moreover, in order
to exclude van der Waals contacts of side chains, the
TINKER software package [24] was used and energy mini-
mization using the Amber94 forcefield was performed.
During the minimization, the main chain atoms were
fixed and RMSD gradient limits were 0.01. Kollman atom
charges were assigned and the rotational bonds of the
peptides were defined with AutoTors [19]. Thus, the dock-
ing parameters and conditions are determined as follows:
the number of energy evaluations is 0.7 million, other
parameters are default values, and main chain angles are
fixed.
To verify the accuracy of the docking results, we analyzed
correlation coefficients between ∆Gbinds (predicted) and
log Ki values (observed). Peptide inhibitors with Ki values
of >10,000 nM were set up the value of 10,000 nM. As
shown in Table 2, the correlation coefficients were 0.75
(caspase-3), 0.83 (caspase-7), 0.95 (caspase-8), and 0.96
(caspase-9). The results show good correlations between
predicted ∆Gbind values by AutoDock3.0 and experimental
Ki values. These observation imply that our docking
parameters and conditions (0.7 million energy evalua-
tions and fixed main chain) are reasonable for predicting
binding modes and affinities of caspase inhibitory
peptides.
Construction of APF score matrix
As a first attempt, APF score matrices for caspases-3, -7, -8,
and -9 were constructed. The APF score matrix shows the
P2-P4 preferences of a caspase (Figure 3), and if a high cor-
relation coefficient is observed between the APF score
derived from APF score matrix and ∆Gbind, the APF score
enables the rapid prediction of ∆Gbind between a caspase
and arbitrary peptides. Figure 4 shows the scatter plot of
APF score vs ∆Gbind in the analysis library and prediction
library. The APF score of caspase-3 showed a preference
for P4: D, V > Q, P3: E > L > P and P2: V > E > P (Figure 3a).
The results obtained for caspase-3 indicate that the pre-
ferred recognition motif for this enzyme is (D/V)EVD.
Interestingly, DEVD is a cleavage site within PARP [17]
and is also the optimal recognition sequence identified
from a positional scanning synthetic combinatorial
library (PS-SCL) [14]. The correlation coefficient for the
caspase-3 analysis library was -0.71 (Figure 4a). To verify
the predictability of APF score, the correlation analysis
was performed using a prediction library comprising of 40
peptides. The correlation coefficient was -0.64 (Figure 4a).
Since the APF score matrix of caspase-7 showed a prefer-
ence for P4: D > E > C, P3: F > E > D, P2: P > I, S > L, the
preferred recognition motif for this enzyme is DFPD (Fig-
ure 3b). DEVD, known as the optimal recognition
sequence, was not shown to be a sequence with the high-
est APF score from the APF score matrix. However, a good
correlation coefficient between APF score and ∆Gbind was
confirmed (Figure 4b). Although known optimal recogni-
tion sequences for caspase-8 and caspase-9 were not
shown from the APF score matrix to be sequences with the
highest APF score, the correlation coefficients between
APF score and ∆Gbind in the analysis library were -0.68 and
-0.76, respectively (Figure 4c and 4d).
Table 2: Prediction of binding affinities of caspase inhibitory peptides by AutoDock3.0
Caspase-3 Caspase-7 Caspase-8 Caspase-9
DEVD ∆Gbind (kcal/mol) -16.83 -17.09 -16.91 -15.79
RMSD (Å) 0.795 1.306 0.632 0.727
IETD ∆Gbind (kcal/mol) -16.07 -15.27 -16.85 -15.72
RMSD (Å) 0.85 1.188 0.486 0.729
WEHD ∆Gbind (kcal/mol) -15.38 -12.34 -14.67 -14.63
RMSD (Å) 0.837 3.358 1.6 1.279
AEVD ∆Gbind (kcal/mol) -15.82 -15.72 -16.1 -15.59
RMSD (Å) 0.84 1.591 0.31 0.771
YVAD ∆Gbind (kcal/mol) -11.2 -11.39 -14.18 -14.24
RMSD (Å) 2.201 2.674 1.493 0.912
Corr. Coeff. of ∆Gbind and log Ki (R) 0.75 0.83 0.95 0.96BMC Pharmacology 2004, 4 http://www.biomedcentral.com/1471-2210/4/7
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APF score matrices of caspases Figure 3
APF score matrices of caspases. The APF score matrices indicate the interaction preferences of amino acids with (a) cas-
pase-3, (b) caspase-7, (c) caspase-8, and (d) caspase-9 at each position (P4-P2). If an APF score is greater than 0, the amino acid 
tends to be favored at a given position. ∆Gth (threshold value of ∆Gbind) of caspases-3, -7, -8, and -9 are -11.05, -10.69, -11.03, 
and -12.12 kcal/mol, respectively.BMC Pharmacology 2004, 4 http://www.biomedcentral.com/1471-2210/4/7
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The scatter of APF score vs ∆Gbind for the Analysis library and Prediction library Figure 4
The scatter of APF score vs ∆Gbind for the Analysis library and Prediction library. The solid line is the result of a lin-
ear regression fit, and r denotes correlation coefficient. (a) caspase-3, (b) caspase-7, (c) caspase-8, and (d) caspas-9.BMC Pharmacology 2004, 4 http://www.biomedcentral.com/1471-2210/4/7
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Consequently, it is revealed that the APF score matrices of
all caspases have the ability to predict ∆Gbind, although
known optimal recognition sequences for caspases-7, -8,
and -9 were not shown directly.
Prediction of binding affinity of caspase peptide inhibitors
A binding affinity prediction for peptide inhibitors for
which experimental data (Ki) have been reported [18] was
performed using APF score matrix. The inhibition of cas-
pases by peptide inhibitors is shown in Table 1. Because
APF score can predict only the binding affinity of the pep-
tide sequence in the inhibitor, the effects of Ac-, Boc- and
-CHO are not taken into account. Peptide inhibitors with
Ki values of >10,000 nM were set to the value of 10,000
nM. The correlation coefficient between log Ki values and
APF score of caspase-3 was -0.69 (Figure 5a). These five
peptides are not included in the analysis library (data not
shown). Caspase-3 is inhibited by peptides in the follow-
ing order: DEVD > AEVD > IETD > WEHD > YVAD. The
APF scores of these peptides are in the same order.
The correlation coefficients between log Ki values and APF
scores of caspase-7 and caspase-8 were -0.77 and -0.82,
respectively (Figure 5b and 5c). When WEHD was omitted
from the correlation analysis of caspase-9, the correlation
coefficient was -0.86 (Figure 5d). In comparison, the APF
score of LEHD, which is utilized as a selective inhibitor of
caspase-9, was 0.44. This score means that LEHD has a
The scatter of the APF score vs log Ki for the peptides in Table 1 Figure 5
The scatter of the APF score vs log Ki for the peptides in Table 1. The solid line is the result of a linear regression fit, 
and r denotes correlation coefficient. (a) caspase-3, (b) caspase-7, (c) caspase-8, and (d) caspas-9.BMC Pharmacology 2004, 4 http://www.biomedcentral.com/1471-2210/4/7
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high binding affinity for caspase-9. Meanwhile, the APF
score of WEHD was 0.59; therefore, it is predicted that
WEHD also has a high binding affinity for caspase-9.
However, the reported Ki for WEHD is not low (508 nM).
APF score of a peptide is the sum of the position-specific
scores of the component amino acids, and it is also
assumed that each amino acid within a peptide contrib-
utes to recognition almost independently. The reason why
WEHD does not has low Ki value may be improper inter-
action of amino acid residues in the peptide.
Construction of enriched library
The locations of inhibitory peptides (Table 1) in the
sorted comprehensive peptide libraries are shown in Fig-
ure 6. All inhibitory peptides with Ki values less than 2 nM
were located within the top 400 peptides in the libraries,
equivalent to 5% of the comprehensive libraries. There-
fore, potent peptide inhibitors are considerably enriched.
Here, the enriched library is defined as the top 5% of the
library. Figure 7 shows schematic overview of the APF
method for constructing of enriched library.
Since the sequences of DEVD, DEPD, DELD, and DGPD,
which are cleavage sites for caspase-3, also satisfy the con-
dition of being in the top 5% of the library, it is expected
that these sequences have a high binding affinity for cas-
pase-3 (DEVD is already known as an inhibitory peptide,
Ac-DEVD-CHO etc.). Meanwhile, the sequences of WEHD
and YVAD have high Ki values, 1960 nM and >10,000 nM,
respectively. These sequences are located at position 6506
(WEHD) and 7322 (YVAD) in the library. The sequences
of DEVD, AEVD, and IETD have low Ki values for caspase-
8, 0.92 nM, 1.6 nM, and 1.05 nM, respectively. The library
of caspase-8 also reflects the high binding affinities of
these sequences, positions of 125, 228, and 328,
respectively.
We, therefore, believe that peptides with high affinities for
each caspase can be efficiently screened from the enriched
library as compared with comprehensive peptide libraries.
Design of a novel caspase-3 inhibitory peptide
To prove the above assumption, we tried to design of a
novel caspase-3 inhibitory peptide from its enriched
library derived from the APF score. Initially, 400 peptides
in the enriched library were docked into the active site of
caspase-3 and their ∆Gbind  were calculated by
AutoDock3.0. During the docking, the number of energy
evaluations was 0.7 million, main chain angles were fixed,
and other parameters were default values. Figure 8 shows
the scatter of APF score vs ∆Gbind for the 400 peptides from
the enriched library and randomly selected 400 peptides
from the non-enriched library (except the 400 peptides
from the comprehensive peptide library). As expected, the
400 peptides in the enriched library had low ∆Gbind (aver-
age ∆Gbind = -15.47 kcal/mol) as compared with that of
peptides in the non-enriched library (average ∆Gbind = -
13.66 kcal/mol).
Finally, the top 80 peptides (1% of comprehensive pep-
tide library) with low ∆Gbind  in the 400 peptides of
enriched library were docked into the active site of cas-
pase-3. During the docking, the number of energy evalua-
tions was 3 million, all of rotational torsion angles were
flexible, and other parameters were default values. Ten
predicted potent inhibitory peptides of caspase-3 are sum-
marized in Table 3. The most potent peptide sequence was
predicted as DEVD (∆Gbind = -16.15 kcal/mol). DELD is
the known cleavage site of D4-GDP dissociation inhibitor
[25]. Seven of the ten peptides have Glu in the P3 position.
Many of the well-known peptide inhibitors of caspases
(see Table 1) also have Glu in the P3 position. Interest-
ingly, only DNLD has Asn in the P3  position. Further-
more, at present, no peptide inhibitors or cleavage site in
the natural substrates of caspase-3 are known to have Asn
in the P3  position.
Inhibitory effect of DNLD on caspase-3 and its binding 
mode
To examine the inhibitory effect of DNLD on caspase-3
activity, recombinant active caspase-3 was treated with
various concentrations of Ac-DNLD-CHO. As shown in
Figure 9, Ac-DNLD-CHO inhibited caspase-3 in a dose-
dependent manner. At 30 nM Ac-DNLD-CHO caused the
inhibition of caspase-3 activity in more than 90% of the
control. The IC50 value was calculated to be 3.17 nM. The
potency of Ac-DNLD-CHO was slightly weak than that of
a well-known peptide inhibitor, Ac-DEVD-CHO (IC50 =
1.34 nM, see Figure 9).
To obtain a better understanding of how these two pep-
tide inhibitors interact with caspase-3, the structural
model for the complex of DNLD with caspase-3 active
pocket was predicted by AutoDock3.0 (Figure 10). We
inspect the important interactions between the caspase-3
active site and the peptide inhibitors: (i) the Leu (P2) in
DNLD forms tight hydrophobic interactions with Tyr204,
Trp206, and Phe256 as well as the Val (P2) in DEVD; (ii)
the Asn (P3) in DNLD forms one hydrogen bond with
Ser209, but the Glu (P3) in DEVD forms two hydrogen
bond with Arg207 and Ser209. These differences may
affect their inhibitory potencies and/or specificities
against caspase-3.
Conclusions
In the present study, we have developed a new in silico
strategy based on APF score for rapid evaluation and
screening of binding peptide to a target protein molecule.
In the Structure-Based Virtual Screening, the
computational calculation time of ∆Gbind is an importantBMC Pharmacology 2004, 4 http://www.biomedcentral.com/1471-2210/4/7
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The locations of peptides (from Table 1) and sequences of cleavage sites in the sorted comprehensive peptide libraries (a) cas- pase-3, (b) caspase-7, (c) caspase-8, and (d) caspase-9 Figure 6
The locations of peptides (from Table 1) and sequences of cleavage sites in the sorted comprehensive peptide 
libraries (a) caspase-3, (b) caspase-7, (c) caspase-8, and (d) caspase-9. Hatched squares show the Enriched libraries. 
Columns of inhibitors show ranking, sequence, APF score and Ki, column of cleavage sites shows ranking, sequence, APF score 
and substrate proteins, and column of optimal sequence shows ranking, sequence, and APF score. These cleavage sites of cas-
pase-3 have been published elsewhere [17,25,29-36]. The optimal recognition sequences are identified from PS-SCL [14].BMC Pharmacology 2004, 4 http://www.biomedcentral.com/1471-2210/4/7
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factor as well as the computational accuracy. On a
common day workstation, it is difficult to predict an
appropriate binding mode and binding free energy for a
peptide, which has 20 to 30 rotational bonds, against a
target protein within a few minutes. Meanwhile, methods
for constructing scoring functions from experimental
cleavage data are rapid enough to predict binding affini-
ties. However, many experimental data points are
required to construct a precise scoring function.
Schematic overview of the APF method Figure 7
Schematic overview of the APF method. Step1: A comprehensive peptide library comprising 8000 peptides is con-
structed. 360 peptides are extracted at random from the comprehensive peptide library and placed in the Analysis library. In a 
similar manner, 40 peptides are placed in the Prediction library. Step2: The binding free energies of the peptides extracted at 
random in Step1 are calculated using AutoDock3.0. Step3: The APF score matrix derived from the Analysis library are con-
structed using equation [1]. Moreover, prediction capability is validated by the APF score matrix against the peptides in the 
Prediction library. Step4: An Enriched library is constructed according to the APF score derived from the APF score matrix.BMC Pharmacology 2004, 4 http://www.biomedcentral.com/1471-2210/4/7
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The APF score developed here allows rapid prediction of
peptide binding affinities. The statistical basis of APF
score is derived from the calculated ∆Gbinds between
randomly extracted peptides and a target caspase using
AutoDock3.0. Therefore, our system does not require
experimental data for constructing a scoring function. It
should be noted that the binding affinities of caspase
inhibitory peptides derived rapidly from the APF score
correlate well with their reported inhibitory kinetics, and
that all peptides with Ki values less than 2 nM were con-
densed in the top 5% of the sorted comprehensive peptide
libraries.
To prove the utility of this method, an attractive candidate
for a new caspase-3 inhibitor in the enriched library was
selected by the APF score. Ac-DNLD-CHO, whose
sequence is so far not known in any caspase substrate, and
has a low ∆Gbind, was chosen and its inhibitory activity
The scatter of APF score vs ∆Gbind for 400 peptides in the enriched library and 400 peptides in the non-enriched library Figure 8
The scatter of APF score vs ∆Gbind for 400 peptides in the enriched library and 400 peptides in the non-
enriched library. The scatter denotes correlation of APF score and ∆Gbind for 400 peptides in enriched library (● , ▲ ) and 
randomly selected 400 peptides in the non-enriched library (◆ ). 400 peptides in enriched library calculated their ∆Gbind by 
AutoDock3.0, and peptides with low ∆Gbind (rank 1–80) denotes circle (● ) and other peptides (81–400) denotes triangular 
(▲ ). The non-enriched library is comprehensive peptide library except 400 peptides in enriched library.BMC Pharmacology 2004, 4 http://www.biomedcentral.com/1471-2210/4/7
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was measured. As expected, Ac-DNLD-CHO had similar
potent inhibitory activity to a well-known inhibitor Ac-
DEVD-CHO. Although the system needs further
validation, it is likely that by using the APF method, pep-
tides with high affinities can be efficiently selected from
the enriched library as compared with random screening.
At present, small peptides have been suggested to have
clinical potential, because in specific protein-protein
interactions occurred in many signalling pathways, small
critical domains on the molecules are revealed to be
involved in their biological activities. Furthermore, many
peptide ligands exist in living organisms. Thus, new com-
putational methods for the identification of active peptide
will be powerful tools for the development of new phar-
maceuticals. The APF method developed here is an attrac-
tive strategy that could discover novel therapeutic agents.
Methods
Materials
Ac-DNLD-CHO was synthesized by Peptide Institute, Inc.
Ac-DEVD-CHO was purchased from Peptide Institute,
Inc. Ac-DEVD-pNA and recombinant human caspase-3
were from CALBIOCHEM.
Caspase-3 Inhibition assay
To determine inhibitory potency of Ac-DNLD-CHO
against caspase-3, an in vitro caspase activity assay was per-
formed. The activity of caspase-3 was measured using Ac-
DEVD-pNA as a substrate. One unit of active recombinant
human caspase-3 was incubated with peptide inhibitor at
indicated concentrations in assay buffer (100 mM NaCl,
50 mM HEPES, 10 mM DTT, 1 mM EDTA, 10% glycerol,
and 0.1% CHAPS, pH 7.4) at 25°C for 30 min with shak-
ing in a 96-well assay plate (CORNING). Then, 100 µM of
Ac-DEVD-pNA was added to each well and absorbance at
405 nm was measured at 25°C using a 96-well plate
reader Wallace 1420 ARVOsx (PerkinElmer) at 1 min
intervals for 60 min.
Preparation of caspase/inhibitory peptide complex 
structure
In this study, we evaluated the binding mode and affinity
of caspase inhibitory peptides by AutoDock3.0, and then
constructed the APF score matrices of caspases-3, -7, -8,
and -9. The coordinates of caspases-3, -7, -8, and -9 were
obtained from the Protein Data Bank (codes 1PAU, 1F1J,
1QTN, and 1JXQ) [26]. Since the caspase-9 inhibitor in
the crystallographic structure is not a 4-amino acid pep-
tide, LEHD, known to be an optimal sequence [14], was
Table 3: Ten Predicted potent peptide inhibitors of caspase-3
Peptide ∆Gbind (kcal/mol) APF score
1 DEVD -16.15 0.73
2 QEPD -15.91 0.60
3 TEPD -15.75 0.53
4 DELD -15.65 0.59
5 QELD -15.63 0.56
6 LEPD -15.57 0.49
7 DNLD -15.45 0.52
8 DQPD -15.39 0.54
9 DPFD -15.16 0.51
10 NEPD -14.95 0.50
Inhibitory effects of DNLD and DEVD on caspase-3 activity Figure 9
Inhibitory effects of DNLD and DEVD on caspase-3 
activity. Caspase-3 was preincubated with various concen-
trations of Ac-DNLD-CHO (● ) or Ac-DEVD-CHO (❍ ), and 
then the activity of caspase-3 was measured with Ac-DEVD-
pNA substrate as described (see "Materials and Methods"). 
The kinetic data presented are the means of three independ-
ent experiments.BMC Pharmacology 2004, 4 http://www.biomedcentral.com/1471-2210/4/7
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The complex structure of active site of caspase-3 with DNLD or DEVD Figure 10
The complex structure of active site of caspase-3 with DNLD or DEVD. Nitrogen, oxygen, and carbon atoms in the 
active site of caspase-3 are illustrated with blue, red, and grey, respectively. (a) Predicted binding mode of DNLD is shown as 
yellow. (b) DEVD in crystal structure (PDB, 1PAU) is shown as orange. During the docking of DNLD against caspase-3, the 
number of energy evaluations was 3 million, all of rotational torsion angles were flexible, and other parameters were default 
values.BMC Pharmacology 2004, 4 http://www.biomedcentral.com/1471-2210/4/7
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docked against caspase-9 using AutoDock3.0 [19], and
the predicted complex structure was used for subsequent
analysis. The crystallographic structures including water
were deleted, and energy minimization using the TINKER
software package [24] was used and energy minimization
using the Amber94 forcefield was performed. During the
minimization, the RMSD gradient limits were 0.01.
Construction of APF Score matrix
The feature of our computational screening strategy is
construction of the Amino acid Positional Fitness (APF)
score matrix for a target protein. This score matrix allow us
to predict binding affinities between a target protein and
peptides rapidly.
Our system comprises four steps as follows (Figure 7).
Step 1. Construction of peptide library
To identify the P2-P4 preferences of each caspase, we con-
structed an analysis library with aspartic acid fixed at P1
and randomized amino acids at P2-P4. In order to analyze
the P4-P3-P2-D motif comprehensively, it is necessary to
analyze 8000 combinations. In this system, 400 peptides
equivalent to 5% of all combinations were extracted at
random, and an analysis library consisting of 360
peptides and a prediction library consisting of 40 peptides
were prepared. To generate initial conformation for pep-
tides in the analysis and prediction libraries, the main
chain coordinates were used for the inhibitory peptides in
the crystallographic structures, and the side chains were
added. Moreover, in order to exclude VDW contacts of
side chains, the TINKER software package [24] was used
and energy minimization using the Amber94 forcefield
was performed. During the minimization, the main chain
atoms were fixed and RMSD gradient limits were 0.01.
Kollman atom charges were assigned and the rotational
bonds of the peptides were defined with AutoTors [19].
Step 2. Calculation of binding free energy using flexible 
ligand docking
The ∆Gbinds of 400 randomly extracted peptides with a
caspase were calculated.
In this study, the main chains of the peptides were fixed
and the side chains were made flexible. During the
docking, the number of energy evaluations was 0.7 mil-
lion and other parameters were default values. The pre-
dicted binding mode of each peptide with caspase was
inspected to determine whether the binding mode was
appropriate. In order to arrange a functional group such as
CHO on the caspase active site, a suitable binding mode
of peptide is important. In generally, good docking solu-
tions have an RMSD of 2.0 Å or less [27], and 3 peptides
with Ki value of >10,000 nM dose not have an RMSD of
2.0 Å or less in Table 2. Therefore, peptides with 2Å or
more RMSD compared with the peptide inhibitor in the
crystallographic structure were defined as not binding to
caspases.
Step 3. Construction of APF Score matrix
APF score matrix based on the frequency of appearance of
20 amino acids at each of positions P4, P3, and P2 were
generated in the analysis library. The APF score for amino
acid i at position j is calculated as follows:
where   is the frequency of amino acid i at position j
among peptides in the analysis library, and   is the
frequency of amino acid i at position j among peptides
below the threshold value (∆Gth) of binding free energy
and RMSD 2 Å in the analysis library.
cij denotes the number of times amino acid i appears at
position j among peptides in the analysis library. nall is the
number of peptides in the analysis library. c'ij denotes the
number of times amino acids i appears at position j
among peptides below the threshold value (∆Gth) of bind-
ing free energy and the RMSD 2 Å in an analysis library,
and nbinder is the number of peptides below the threshold
value (∆Gth) and RMSD 2 Å. The range of position j is
from 1 to 3, and corresponding to P2 to P4. The range of
amino acid i is from 1 to 20, and corresponding to indi-
vidual amino acids.
By using APF score matrix, it becomes possible to calculate
the APF score, which shows the binding affinity of a
peptide and a caspase. The APF score of a peptide is given
 by Equation [4].
A peptide with the P4-P3-P2-D motif is represented by a 20
× 3 matrix (cij) of 0s and 1s, where cij = 1 if amino acid i is
at position j [28].
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Correlation analysis of APF score and ∆Gbind of peptides
consisting in the analysis library was carried out. If a high
correlation is observed between APF score and ∆Gbind, it
becomes possible to predict ∆Gbind using APF score. A
threshold value (∆Gth) was set up the value that makes the
correlation coefficient between APF score and ∆Gbind max-
imal.
Next, correlation analysis between APF score and ∆Gbind of
peptides involved in a prediction library was carried out.
Here, the APF score was calculated by using APF score
matrix generated from the analysis library, and the predic-
tion capability was validated.
Step 4. Construction of an enriched library by APF score
It is assumed that potent peptide inhibitors are distributed
randomly in the comprehensive peptide library. The APF
scores of all peptides in the comprehensive peptide library
were calculated using APF score matrix generated from the
analysis library. Since a high APF score reflects high bind-
ing affinity, peptides in the comprehensive peptide library
were sorted in descending order according to their APF
score. This operation takes the high affinity peptides,
which are distributed throughout the library, condenses
them at a higher rank in the library. The enriched library
was defined as the top 5% of the sorted comprehensive
peptide library.
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